Plasmin is a specific stimulus of the 5-lipoxygenase pathway of human peripheral monocytes

Thrombosis and Haemostasis

Volumn 76, Issue 4, 1996, Pages 561-568

  Weide, Ingo ^a   Tippler, Bettina ^a   Syrovets, Tatjana ^a   Simmet, Thomas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ARACHIDONATE 5 LIPOXYGENASE; CATHEPSIN G; CHYMOTRYPSIN A; CYCLIC GMP; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; LYSINE; PERTUSSIS TOXIN; PLASMIN; PLASMINOGEN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SERINE PROTEINASE; THROMBOXANE B2; TRANEXAMIC ACID;

ADULT; ARTICLE; BINDING SITE; BLOOD CLOTTING; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0029846337     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650623     Document Type: Article

References (50)

1. Kozin F, Cochrane CG. The contact activation system of plasma. Biochemistry and pathophysiology. In: Inflammation: Basic Principles and Clinical Correlates. Second Edition. Gallin JI, Goldstein IM, Snyderman R, eds. Raven Press, New York, NY 1992; pp 103-21.
2. Kaplan AP, Silverberg M. The coagulation-kinin pathway of human plasma. Blood 1987; 70: 1-15.
3. 4 formation by whole human blood. Eicosanoids 1988; 1: 107-10.
4. Simmet Th, Luck W. Clotting of whole human blood induces cysteinyl-leukotriene formation. Thromb Res 1989; 54: 423-33.
5. Simmet Th, Weide I. Thromboxane and cysteinyl-leukotriene formation are differentially activated in spontaneously clotting whole human blood in vitro. Thromb Res 1991; 62: 249-61.
6. Weide I, Simmet Th. Leukotriene formation by peripheral monocytes in contact-activated human blood. Thromb Res 1993; 71: 185-92.
7. Weide I, Römisch J, Simmet Th. Contact activation triggers stimulation of the monocyte 5-lipoxygenase pathway via plasmin. Blood 1994; 83: 1941-51.
8. Silverstein RL, Friedlander RJ, Jr, Nicholas RL, Nachman RL. Binding of Lys-plasminogen to monocytes/macrophages. J Clin Invest 1988; 82: 1948-55.
9. Palmer S, Wakelam MJO. Mass measurement of inositol 1,4,5-trisphosphate using a specific binding assay. In: Methods in Inositide Research. Irvine RF, ed. Raven Press, New York, NY 1990; pp 127-34.
10. Nibbering PH, Zomerdijk TPL, van Haastert PJM, van Furth R. A competition binding assay for determination of the inositol (1,4,5)-trisphosphate content of human leucocytes. Biochem Biophys Res Commun 1990; 170: 755-62.
11. Friberger P, Knös M, Gustavsson S, Aurell L, Claeson G. Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 1978; 7: 138-45.
12. Lu H, Soria C, Li H, Soria J, Lijnen HR, Perrot JY, Caen JP. Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregation. Thromb Haemost 1991; 65: 67-72.
13. 2+ mobilization, and cellular responses to chemoattractants in human monocytes. J Immunol 1986; 137: 271-5.
14. Sozzani S, Luini W, Molino M, Jilek P, Bottazzi B, Cerletti C, Matsushima K, Mantovani A. The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. J Immunol 1991; 147: 2215-21.
15. Pliska V. Models to explain dose-response relationships that exhibit a downturn phase. TIPS 1994; 15: 178-81.
16. Rovati EG, Nicosia S. Lower efficacy: Interaction with an inhibitory receptor or partial agonism? TIPS 1994; 15: 140-4.
17. Kenakin T. Agonist-receptor efficacy I: Mechanisms of efficacy and receptor promiscuity. TIPS 1995; 16: 188-92.
18. Snyderman R, Uhing RJ. Chemoattractant stimulus-response coupling. In: Inflammation: Basic Principles and Clinical Correlates. Second Edition. Gallin JI, Goldstein IM, Snyderman R, eds. Raven Press, New York, NY, 1992; pp 421-39.
19. Castellino FJ, Sodetz JM. Rabbit plasminogen and plasmin isozymes. Methods Enzymol 1976; 45: 273-86.
20. Bar-Shavit R, Kahn A, Fenton JW, Wilner GD. Chemotactic response of monocytes to thrombin. J Cell Biol 1983; 96: 282-5.
21. Bar-Shavit R, Kahn AL, Mann KG, Wilner GD. Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci USA 1986; 83: 976-80.
22. Weide I, Simmet Th. Novel chemotactic activation specific for human peripheral monocytes. Inflammation Res 1995 (Suppl 3) 44: S246.
23. Schafer AI, Adelman B. Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest 1985; 75: 456-61.
24. Schafer AI, Maas AK, Ware JA, Johnson PC, Rittenhouse SE, Salzman EW. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin. J Clin Invest 1986; 78: 73-9.
25. Pawlowski NA, Kaplan G, Hamill AL, Cohn ZA, Scott WA. Arachidonic acid metabolism by human monocytes. J Exp Med 1983; 158: 393-412.
26. Balter MS, Toews GB, Peters-Golden M. Different patterns of arachidonate metabolism in autologous human blood monocytes and alveolar macrophages. J Immunol 1989; 142: 602-8.
27. Goppelt-Struebe M. Regulation of prostaglandin endoperoxide synthase (Cyclooxygenase) isoenzyme expression. Prostaglandins Leukotrienes Essent Fatty Acids 1995; 52: 213-22.
28. 2 enzymes regulate distinct aspects of arachidonic acid metabolism. Inflammation Res 1995; 44 (Suppl 3): S258.
29. Ryan TJ, Lai L, Malik AB. Plasmin generation induces neutrophil aggregation: dependence on the catalytic and lysine binding sites. J Cell Physiol 1992; 151: 255-61.
30. Chang WC, Shi GY, Chow YH, Chang LC, Hau JS, Lin MT, Jen CJ, Wing LYC, Wu HL. Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cells. Am J Physiol 1993; 264: C271-C81.
31. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of α-enolase as a possible candidate plasminogen receptor. Biochemistry 1991; 30: 1682-91.
32. Miles LA, Plow EF. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost 1987; 58: 936-42.
33. Miles LA, Plow EF. Plasminogen receptors: Ubiquitous sites for cellular regulation of fibrinolysis. Fibrinolysis 1988; 2: 61-71.
34. Félez J, Miles LA, Plescia J, Plow EF. Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines. J Cell Biol 1990; 111: 1673-83.
35. Hajjar KA. Cellular receptors in the regulation of plasmin generation. Thromb Haemost 1995; 74: 294-301.
36. Miles LA, Dahlberg CM, Levin EG, Plow EF. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 1989; 28: 9337-43.
37. Falcone DJ, Borth W, Mathew J, Guevara C, Hajjar KA. Annexin II is a plasminogen receptor on THP-1 macrophages. FASEB J 1995; 9: 2388.
38. Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
39. Vu TKH, Wheaton VI, Hung DT, Charo I, Coughlin SR. Domains specifying thrombin-receptor interaction. Nature 1991; 353: 674-7.
40. Kitagawa S, Takaku F, Sakamoto S. Evidence that proteases are involved in Superoxide production by human polymorphonuclear leukocytes and monocytes. J Clin Invest 1980; 65: 74-81.
41. King CH, Goralnik CH, Kleinhenz PJ, Marino JA, Sedor JR, Mahmoud AF. Monoclonal antibody characterization of a chymotrypsin-like molecule on neutrophile membrane associated with cellular activation. J Clin Invest 1987; 79: 1091-8.
42. 1-antichymotrypsin. J Immunol 1991; 146: 2388-93.
43. 1-antichymotrypsin and is stimulated by proteinases. J Exp Med 1988; 168: 1293-306.
44. 4 and platelet-activating factor. Eur J Biochem 1989; 182: 661-6.
45. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341: 197-205.
46. Smith CD, Cox CC, Synderman R. Receptor-coupled activation of phosphoinositide-specific phospholipase C by an N protein. Science 1986; 232: 97-100.
47. Belenky SN, Robbins RA, Rubinstein I. Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukocyte Biol 1993; 53: 498-503.
48. G-monomethyl-L-arginine: A role for cyclic GMP. Blood 1989; 74: 1885-7.
49. Lam BK, Austen KF. Leukotrienes. Biosynthesis, release, and actions. In: Inflammation: Basic Principles and Clinical Correlates. Second Edition. Gallin JI, Goldstein IM, Snyderman R, eds. Raven Press, New York, NY, 1992; pp 139-47.
50. 4 and f-Met-Leu-Phe. Am J Pathol 1987; 127: 157-67.